Skip to main content

NEOSTIGMINE METHYLSULFATE

NDC 51662-1557 · HF Acquisition Co LLC, DBA HealthFirst

Generic nameNEOSTIGMINE METHYLSULFATE
Dosage formINJECTION
RouteINTRAVENOUS
Active ingredient(s)NEOSTIGMINE METHYLSULFATE
Strength1 mg/mL
Pharmacologic classCholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]
Marketing categoryANDA

Packages

51662-1557-3 — 10 POUCH in 1 CASE (51662-1557-3) / 1 CARTON in 1 POUCH (51662-1557-2) / 1 VIAL, MULTI-DOSE in 1 CARTON / 10 mL in 1 VIAL, MULTI-DOSE

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

25021-610 — Neostigmine Methylsulfate, 25021-611 — Neostigmine Methylsulfate, 31722-994 — neostigmine methylsulfate, 31722-995 — neostigmine methylsulfate, 42023-188 — NEOSTIGMINE METHYLSULFATE, 42023-189 — NEOSTIGMINE METHYLSULFATE, 42023-269 — neostigmine methylsulfate and glycopyrrolate, 43598-528 — Neostigmine, 43598-529 — Neostigmine, 43598-945 — Neostigmine Methylsulfate, 51754-1200 — Neostigmine Methylsulfate, 55150-348 — NEOSTIGMINE METHYLSULFATE, 55150-349 — NEOSTIGMINE METHYLSULFATE, 63323-413 — Neostigmine Methylsulfate, 63323-415 — Neostigmine Methylsulfate, 65145-111 — Neostigmine Methylsulfate, 65145-112 — Neostigmine Methylsulfate, 65219-811 — Neostigmine Methylsulfate, 68083-383 — Neostigmine methylsulfate, 68083-384 — Neostigmine methylsulfate, +32 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels